E. Sinakos

发表

Anticholinergic syndrome induced by toxic plants.

E. Cholongitas, S. Soulaidopoulos, E. Sinakos, 2017, World journal of emergency medicine.

Epidemiology, Clinical Data, and Treatment of Viral Hepatitis in a Large Cohort of Intravenous Drug Users

M. Raptopoulou-Gigi, E. Sinakos, E. Gigi, 2013, Journal of addiction medicine.

Liraglutide in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials.

A. Haidich, Maria Kalogirou, D. Patoulias, 2020, Clinics and research in hepatology and gastroenterology.

Update on the association of hepatitis B with intrahepatic cholangiocarcinoma: Is there new evidence?

C. Emmanouilides, E. Sinakos, N. Fragkou, 2021, World journal of gastroenterology.

Chronic kidney disease in patients with non-alcoholic fatty liver disease: What the Hepatologist should know?

C. Liava, Maria Kalogirou, E. Sinakos, 2020, Annals of hepatology.

Deferasirox improves liver fibrosis in beta‐thalassaemia major patients. A five‐year longitudinal study from a single thalassaemia centre

N. Sousos, E. Vlachaki, A. Daniilidis, 2018, British journal of haematology.

The role of sorafenib in downsizing hepatocellular carcinoma prior to liver transplantation and in treating tumor recurrence

G. Selvaggi, A. Tzakis, E. Sinakos, 2011, Annals of gastroenterology.

Emerging advances in the pharmacologic treatment of nonalcoholic steatohepatitis and related cirrhosis

C. Liava, R. Loomba, E. Sinakos, 2022, Annals of gastroenterology.

Treatment of chronic hepatitis C with direct‐acting antivirals in patients with β‐thalassaemia major and advanced liver disease

I. Goulis, J. Koskinas, Konstantinos Maragkos, 2017, British Journal of Haematology.

Original article Outcome of gallbladder polyps in patients with primary sclerosing cholangitis

K. Lindor, J. Keach, S. Treeprasertsuk, 2012 .

Clinicopathological correlations in a series of adult patients with non‐alcoholic fatty liver disease

P. Hytiroglou, V. Kotoula, E. Sinakos, 2010, Pathology international.

The significance of paired biopsies in estimating disease progression in patients with nonalcoholic steatohepatitis.

C. Liava, P. Hytiroglou, E. Sinakos, 2019, European journal of gastroenterology & hepatology.

High‐dose ursodeoxycholic acid increases risk of adverse outcomes in patients with early stage primary sclerosing cholangitis

K. Lindor, K. Kowdley, V. Luketic, 2011, Alimentary pharmacology & therapeutics.

In the issue of March 25, 2021 of the New England Journal of Medicine, Newsome et al. published the results of a phase II clinical trial of semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1RA), given once-daily,

C. Liava, E. Sinakos, 2021 .

Peripheral endothelial and microvascular damage in liver cirrhosis: A systematic review and meta‐analysis

P. Sarafidis, M. Theodorakopoulou, I. Goulis, 2022, Microcirculation.

Safety of transarterial chemoembolization plus sorafenib combination treatment in unresectable hepatocellular carcinoma

A. Drevelegas, E. Sinakos, E. Akriviadis, 2010, Scandinavian journal of gastroenterology.

Liver Imaging Reporting and Data System criteria for the diagnosis of hepatocellular carcinoma in clinical practice: A pictorial minireview

C. Liava, D. Chourmouzi, S. Potsi, 2022, World journal of gastroenterology.

Enhanced recovery after surgery in liver transplantation: Challenges and feasibility

O. Giouleme, G. Tsoulfas, I. Goulis, 2022, World journal of transplantation.

Endothelial and microvascular function in liver cirrhosis: an old concept that needs re-evaluation?

M. Theodorakopoulou, I. Goulis, P. Sarafidis, 2022, Annals of gastroenterology.

Inflammatory Bowel Disease in Primary Sclerosing Cholangitis: A Robust yet Changing Relationship

K. Lindor, W. Sandborn, E. Loftus, 2013, Inflammatory bowel diseases.

Transient Elastography (Fibroscan) in Patients with Chronic Hepatitis B

P. Hytiroglou, G. Papatheodoridis, S. Manolakopoulos, 2012 .

Role of immunotherapy in downsizing hepatocellular carcinoma prior to liver transplantation

I. Goulis, E. Sinakos, A. Chatziioannou, 2022, World journal of transplantation.

Outcome of patients with primary sclerosing cholangitis and ulcerative colitis undergoing colectomy.

Emma M. B. Weeding, E. Weeding, E. Björnsson, 2013, World journal of gastrointestinal pharmacology and therapeutics.

Many patients with primary sclerosing cholangitis and increased serum levels of carbohydrate antigen 19-9 do not have cholangiocarcinoma.

W. Kim, K. Lindor, A. Saenger, 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Treatment options for primary sclerosing cholangitis

K. Lindor, E. Sinakos, 2010, Expert review of gastroenterology & hepatology.

Nucleos(t)ide analogues for the prevention of hepatitis B recurrence after liver transplantation do not affect serum phosphorus levels

E. Cholongitas, I. Goulis, V. Papanikolaou, 2016, Annals of gastroenterology.

Toxic hepatic injury mimicking ascending cholangitis: is Pyrus amygdaliformis to blame?

P. Hytiroglou, E. Sinakos, E. Akriviadis, 2008, Virchows Archiv.

Antiviral therapy leads to histological improvement of HBeAg-negative chronic hepatitis B patients

P. Hytiroglou, E. Sinakos, E. Akriviadis, 2015, Annals of gastroenterology.

AUTOIMMUNE , CHOLESTATIC AND BILIARY DISEASE Bile Acid Changes After High-Dose Ursodeoxycholic Acid Treatment in Primary Sclerosing Cholangitis : Relation to Disease Progression

K. Lindor, K. Kowdley, H. Marschall, 2010 .

Update on inflammatory bowel disease in patients with primary sclerosing cholangitis.

E. Sinakos, Anysia Semertzidou, Christos Tsaitas, 2014, World journal of hepatology.

High-Dose Ursodeoxycholic Acid Is Associated With the Development of Colorectal Neoplasia in Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis

K. Lindor, K. Kowdley, V. Luketic, 2011, The American Journal of Gastroenterology.

Pathogenesis and management of pruritus in cholestatic liver disease

K. Lindor, A. Gossard, E. Sinakos, 2012, Journal of gastroenterology and hepatology.

Safety and Efficacy of Combination Therapy with Pegylated Interferon Alpha-2a and Ribavirin in Treating Patients with Chronic Hepatitis C and Beta-Thalassaemia Major: A Greek Single-Center Experience

P. Paschos, V. Perifanis, E. Vlachaki, 2011, Acta Haematologica.

Is liver stiffness really unrelated to liver iron concentration?

V. Perifanis, M. Raptopoulou-Gigi, I. Tsatra, 2010, British journal of haematology.

Treating nonalcoholic steatohepatitis with antidiabetic drugs: Will GLP-1 agonists end the struggle?

E. Sinakos, M. Kalogirou, 2018, World journal of hepatology.

Virologic response and resistance to lamivudine in patients with chronic hepatitis B: a ten-year retrospective analysis.

M. Raptopoulou-Gigi, E. Vrettou, E. Sinakos, 2012, Hippokratia.

Gastrointestinal stromal tumors: a pictorial review.

A. Drevelegas, E. Akriviadis, D. Chourmouzi, 2009, Journal of gastrointestinal and liver diseases : JGLD.

Corticosteroids Reduce Risk of Death Within 28 Days for Patients With Severe Alcoholic Hepatitis, Compared With Pentoxifylline or Placebo-a Meta-analysis of Individual Data From Controlled Trials.

D. J. Kim, A. Duhamel, S. Atkinson, 2018, Gastroenterology.

3 Tesla diffusion‐weighted MRI for assessing liver fibrosis in nonalcoholic fatty liver disease

A. Drevelegas, P. Hytiroglou, D. Chourmouzi, 2013, Hepatology.

Serum lipids in primary sclerosing cholangitis.

K. Lindor, Ghulam Abbas, E. Sinakos, 2012, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Editorial: Bile Acid Profiles in Intrahepatic Cholestasis of Pregnancy: Is This the Solution to the Enigma of Intrahepatic Cholestasis of Pregnancy?

K. Lindor, E. Sinakos, 2010, The American Journal of Gastroenterology.

Varices in Early Histological Stage Primary Biliary Cirrhosis

K. Lindor, P. Angulo, E. Sinakos, 2011, Journal of clinical gastroenterology.

Optimizing biochemical markers as endpoints for clinical trials in primary biliary cirrhosis

K. Lindor, E. Sinakos, R. Jorgensen, 2011, Liver international : official journal of the International Association for the Study of the Liver.

Transarterial embolization for the treatment of complicated liver hemangiomas: A report of two cases and review of the literature

D. Chourmouzi, E. Sinakos, E. Akriviadis, 2018, Clinical and molecular hepatology.

Severe autoimmune hemolytic anemia complicated with liver decompensation and invasive aspergillosis in a patient with chronic hepatitis C during treatment with peg-interferon-a and ribavirin.

M. Raptopoulou-Gigi, E. Sinakos, E. Gigi, 2009, Journal of gastrointestinal and liver diseases : JGLD.

Long-term outcomes of patients with primary biliary cirrhosis and hepatocellular carcinoma.

K. Lindor, J. Keach, A. Gossard, 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Comparison of creatinine and cystatin formulae with 51Chromium‐ethylenediaminetetraacetic acid glomerular filtration rate in patients with decompensated cirrhosis

E. Cholongitas, A. Notopoulos, I. Goulis, 2016, Journal of Gastroenterology and Hepatology.

Estimation of glomerular filtration rate in patients with cirrhosis: evaluation of equations currently used in clinical practice and validation of Royal Free Hospital cirrhosis glomerular filtration rate

I. Goulis, E. Sinakos, A. Protopapas, 2020, European journal of gastroenterology & hepatology.

Is there Still a Role for Ursodeoxycholic Acid Treatment in Patients with Inflammatory Bowel Disease Associated with Primary Sclerosing Cholangitis

K. Lindor, E. Sinakos, 2012 .

Colon neoplasms develop early in the course of inflammatory bowel disease and primary sclerosing cholangitis.

K. Lindor, P. Charatcharoenwitthaya, E. Sinakos, 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

The clinical presentation of Von Meyenburg complexes.

A. Drevelegas, E. Akriviadis, D. Dimopoulou, 2011, Hippokratia.

Value of 3 Tesla diffusion-weighted magnetic resonance imaging for assessing liver fibrosis

J. Talwalkar, A. Drevelegas, P. Hytiroglou, 2015, Annals of gastroenterology.

Primary hepatic neuroendocrine tumor treated with liver transplantation.

E. Katsiki, E. Sinakos, A. Chatziioannou, 2022, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Effects of an active lifestyle on the physical frailty of liver transplant candidates

O. Giouleme, G. Tsoulfas, I. Goulis, 2022, World journal of transplantation.

Safety of deferasirox in sickle cell disease patients with co‐existing liver impairment

A. Tsapas, E. Vlachaki, E. Sinakos, 2012, British journal of haematology.

Treatment of intravenous drug users with chronic hepatitis C: treatment response, compliance and side effects.

E. Vrettou, E. Sinakos, E. Gigi, 2007, Hippokratia.

ASSESSMENT OF HISTOLOGIC RISK FACTORS FOR HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CHRONIC HEPATITIS B OF ADVANCED STAGE

P. Hytiroglou, G. Germanidis, A. Haidich, 2023, Pathology - Research and Practice.

350 TRANSIENT ELASTOGRAPHY (FIBROSCAN) IN PATIENTS WITH CHRONIC HEPATITIS B IN EVERYDAY CLINICAL PRACTICE

P. Hytiroglou, G. Papatheodoridis, S. Manolakopoulos, 2011 .

Plasma Lipids Profile in the Prediction of Non-Alcoholic Steatohepatitis in Adults: A Case-Control Study

M. Chourdakis, H. Gika, G. Germanidis, 2023, International journal of molecular sciences.